Results
1 -
10 of
191Yi Cui, Samantha Kwok, Andrew Bucholtz, Boyd Davis, Ralph A. Whitney and Philip G. Jessop.
The effect of substitution on the utility of piperidines and octahydroindoles for reversible hydrogenstorage, New J. Chem., 2008, 32, 1027. Anna-Marja Aura, Ismo Mattila, Tuulia Hyötyläinen, Peddinti Gopalacharyulu, Catherine Bounsaythip, Matej Orešič and Kirsi-Marja Oksman-Caldentey.
Drug metabolome of the Simvastatin formed by human intestinal microbiota in vitro, Mol. Biosyst., 2011, 7, 437. Annabel C. Murphy.
Metabolic engineering is key to a sustainable chemical industry, Nat. Prod. Rep., 2011, 28, 1406. Stephen G. Davies, David Díez, Sara H. Dominguez, Narciso M. Garrido, Dennis Kruchinin, Paul D. Price and Andrew D. Smith.
Cyclic ß-amino acid derivatives: synthesis via lithium amide promoted tandem asymmetric conjugate addition–cyclisation reactions, Org. Biomol. Chem., 2005, 3, 1284. Andreas Lemmerer and Manuel A. Fernandes.
Adventures in co-crystal land: high Z', stoichiometric variations, polymorphism and phase transitions in the co-crystals of four liquid and solid cyclic carboxylic acids with the supramolecular reag
ent isonicotinamide, New J. Chem., 2012, 36, 2242. Muro F; Iimura S; Yoneda Y; Chiba J; Watanabe T; Setoguchi M; Takayama G; Yokoyama M; Takashi T; Nakayama A; Machinaga N.
A novel and potent VLA-4 antagonist based on trans-4-substituted cyclohexanecarboxylic acid., Bioorganic & medicinal chemistry Škopić M. Klika, Bugain O., Jung K., Onstein S., Brandherm S., Kalliokoski T., Brunschweiger A..
Design and synthesis of DNA-encoded libraries based on a benzodiazepine and a pyrazolopyrimidine scaffold, Med. Chem. Commun., 2016 Setoguchi M; Iimura S; Sugimoto Y; Aonuma M; Takashi T; Nakayama A; Machinaga N; Yoneda Y; Chiba J; Watanabe T; Muro F; Iigo Y; Takayama G; Yokoyama M; Taira T.
A novel, potent, and orally active VLA-4 antagonist with good aqueous solubility: trans-4-[1-[[2-(5-Fluoro-2-methylphenylamino)-7-fluoro-6-benzoxazolyl]acetyl]-(5S)-[methoxy(methyl)amino]methyl-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid., Bioorganic & medicinal chemistry Setoguchi M; Iimura S; Sugimoto Y; Aonuma M; Takashi T; Nakayama A; Machinaga N; Yoneda Y; Chiba J; Watanabe T; Muro F; Iigo Y; Takayama G; Yokoyama M; Taira T.
Identification of trans-4-[1-[[7-fluoro-2-(1-methyl-3-indolyl)-6-benzoxazolyl]acetyl]-(4S)-fluoro-(2S)-pyrrolidinylmethoxy]cyclohexanecarboxylic acid as a potent, orally active VLA-4 antagonist., Bioorganic & medicinal chemistry